Company · CIK 0001411685 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Vistagen Therapeutics, Inc. · VTGN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 AForm 4 → | Jul 2, 4:34 pm EDT | Reid G. AdlerChief Legal Officer | 36,818 | $0.1921 | $7,073 | 60,868 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 4:17 pm EDT | Nick B. TresslerChief Financial Officer | 11,712 | $0.1921 | $2,250 | 11,712 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 4:16 pm EDT | Shawn SinghPresident and CEO, Director | 36,818 | $0.1921 | $7,073 | 54,846 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 AForm 4 → | Jul 31, 8:56 am EDT | Douglas J WilliamsonDirector | 40,826 | — | — | 40,826 | — |